The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Recent insights into the cellular biology of atherosclerosis
Open accessAbstract
Atherosclerosis occurs in the subendothelial space (intima) of medium-sized arteries at regions of disturbed blood flow and is triggered by an interplay between endothelial dysfunction and subendothelial lipoprotein retention. Over time, this process stimulates a nonresolving inflammatory response that can cause intimal destruction, arterial thrombosis, and end-organ ischemia. Recent advances highlight important cell biological atherogenic processes, including mechanotransduction and inflammatory processes in endothelial cells, origins and contributions of lesional macrophages, and origins and phenotypic switching of lesional smooth muscle cells. These advances illustrate how in-depth mechanistic knowledge of the cellular pathobiology of atherosclerosis can lead to new ideas for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Adding growth factors such as VEGF and PDGF to PLCL vascular scaffolds can effectively promote vascular endothelialization, accelerate migration and aggregation of endothelial cells and smooth muscle cells, and promote vascular regeneration and reconstruction [161].”
From Application of PLCL as a biodegradable polymer in biomedical engineering (2026) · cites this paper as [161]
Experimental — accuracy not yet measuredIn the citing paper
“Atherosclerosis is an age‐associated vascular disease characterised by the formation of plaques in arterial vessels, which can lead to the development of various cardiovascular disorders including myocardial infarction, stroke and sudden cardiac death (Tabas et al, 2015).”
From The struggle of a good friend getting old: cellular senescence in viral responses and therapy (2021) · cites this paper as Tabas et al, 2015
In the citing paper
“Hypercholesterolemia, defined by elevated plasma low‐density lipoprotein (LDL) cholesterol, is a well‐established risk factor not only for cardiovascular disease (Borén et al. 2022; Steinberg 2013; Tabas et al. 2015; Boffa and Koschinsky 2019), but also for cognitive decline and dementia in later life (Kivipelto et al. 2001; Kivipelto and Solomon 2006; Livingston et al. 2024; Sparks et al. 2000, 2”
From LDL Cholesterol Modulates Astrocyte Metabolism, Lipid Handling, and Morphology: Evidence From In Vitro and In Vivo Models (2026) · cites this paper as Tabas et al. 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094
Macrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Self-citationIntegrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Tabas, I. A., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,655
Self-citationThe immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,389
Nathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
Wang, K., Wang, W., Lei, L., Lan, Y., Liu, Q., Ren, L., & Wu, S. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114210 · Cited by 16
Macrophage Anti-inflammatory Behaviour in a Multiphase Model of Atherosclerotic Plaque Development
Ahmed, I. U., Byrne, H. M., & Myerscough, M. R. (2023) · Bulletin of Mathematical Biology · doi:10.1007/s11538-023-01142-7 · Cited by 16
Shen, L., Tian, Q., Ran, Q., Gan, Q., Hu, Y., Du, D., Qin, Z., Duan, X., Zhu, X., & Huang, W. (2024) · Biomolecules · doi:10.3390/biom14121623 · Cited by 18
Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population
Yang, W., Petit, T., Thijs, L., Zhang, Z., Jacobs, L., Hara, A., Wei, F., Salvi, E., Citterio, L., Carpini, S. D., et al. (2015) · BMC Genetics · doi:10.1186/s12863-015-0272-2 · Cited by 16
Ghousifam, N., Mortazavian, H., Bhowmick, R., Vasquez, Y., Blum, F. D., & Gappa‐Fahlenkamp, H. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.12.072 · Cited by 16
Huang, Z., Liang, N., Damdimopoulos, A., Fan, R., & Treuter, E. (2018) · The FASEB Journal · doi:10.1096/fj.201801123r · Cited by 16
Polfus, L. M., Raffield, L. M., Wheeler, M. M., Tracy, R. P., Lange, L. A., Lettre, G., Miller, A. K., Correa, A., Bowler, R. P., Bis, J. C., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy360 · Cited by 16
Feng, X., Qi, P., Wang, L., Lü, J., Wang, H. F., Wang, J., Hu, S., & Wang, D. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.105543 · Cited by 16
Jiang, T., Zhang, W., & Wang, Z. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s243666 · Cited by 16
Li, T., Wang, B., Ding, H., Chen, S., Cheng, W., Yang, L., Wu, X., Wang, L., Jiang, Y., Lu, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.857331 · Cited by 18
Brown, R. B. (2019) · Biochimie · doi:10.1016/j.biochi.2019.09.020 · Cited by 18
Li, D. X., Liu, L., Yang, S., Xing, Y., Pan, L., Zhao, R., Zhao, Y., Huang, G., & Wu, M. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5569666 · Cited by 15
Rautureau, Y., Berlatie, M., Rivas, D., Uy, K., Blanchette, A., Miquel, G., Higgins, M., Mecteau, M., Nault, A., Villeneuve, L. R., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac085 · Cited by 15
van der Vorst, E. P. C., Maas, S. L., Theodorou, K., Peters, L. J. F., Jin, H., Rademakers, T., Gijbels, M. J., Rousch, M., Jansen, Y. J. F. M., Weber, C., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.974918 · Cited by 15
Adenosine signaling as target in cardiovascular pharmacology
Antonioli, L., Fornai, M., Pellegrini, C., Pacher, P., & Haskó, G. (2023) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2023.102393 · Cited by 18
You, P., Yang, A., Sun, Y., Zhang, H., Zeng, Y., Hao, Y., Xiong, J., Ma, S., Zhang, H., Liu, B., et al. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.112316 · Cited by 16
Diabetic Retinopathy and Cardiovascular Disease: A Literature Review
Yu, W., Yang, B., Xu, S., Gao, Y., Huang, Y., & Wang, Z. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s438111 · Cited by 20
Exercise, exerkines and exercise mimetic drugs: Molecular mechanisms and therapeutics
Samant, V., & Prabhu, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123225 · Cited by 15
Li, T., Zhang, J.-J., Liu, B., Luo, X., Ma, Q., & Peng, J. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0142 · Cited by 15
Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr −/− mice
Zhao, L., Cozzo, A. J., Johnson, A., Christensen, T., Freemerman, A. J., Bear, J. E., Rotty, J. D., Bennett, B. J., & Makowski, L. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.009 · Cited by 15
Chalcone Derivatives Enhance ATP-Binding Cassette Transporters A1 in Human THP-1 Macrophages
Teng, I.-J., Tsai, M., Shih, S.-F., Tsuei, B.-F., Chang, H. W., Chuang, Y., Lin, C., Chern, C., & Chen, S. (2018) · Molecules · doi:10.3390/molecules23071620 · Cited by 15
Li, X., Zhou, J., Dou, Y., Shi, Y., Wang, Y., Hong, J., Zhao, J., Zhang, J., Yang, Y., Zhou, M., et al. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02968-7 · Cited by 15
Clonal Expansion in Cardiovascular Pathology
Lin, A., Brittan, M., Baker, A. H., Dimmeler, S., Fisher, E. A., Sluimer, J. C., & Misra, A. (2024) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.04.008 · Cited by 13
Maddila, S. C., Voshavar, C., Arjunan, P., Chowath, R. P., Rachamalla, H. K., Balakrishnan, B., Balasubramanian, P., Banerjee, R., & Marepally, S. K. (2021) · Molecules · doi:10.3390/molecules26154626 · Cited by 14
Kamato, D., Ilyas, I., Xu, S., & Little, P. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112964 · Cited by 14
Liu, S. Y., Zhao, Y., Yao, H., Zhang, L., Chen, C., Zheng, Z., & Jin, S. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113688 · Cited by 13
Yiğit, E., Değer, O., Korkmaz, K., Yiğit, M. H., Uydu, H. A., Mercantepe, T., & Demir, S. (2024) · Nutrients · doi:10.3390/nu16121861 · Cited by 15
SUCNR 1 promotes atherosclerosis by inducing endoplasmic reticulum stress mediated ER-mito crosstalk
Yuan, C., Yu, B., Li, L., Chen, J., Qin, W., Zhou, Z., Su, M., Wang, D., Zhang, Y., Wu, Q., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113510 · Cited by 15
Li, T., Zhang, J.-J., Liu, B., Liu, W., Wu, Y., Xiong, X.-M., Luo, X., Ma, Q., & Peng, J. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1198-y · Cited by 14
Study on the levels of glycosylated lipoprotein in patients with coronary artery atherosclerosis
Luo, W., He, Y., Ding, F., Nie, X., Li, X., Song, H.-L., & Li, G. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22650 · Cited by 15
Is Interleukin-38 a key player cytokine in atherosclerosis immune gene therapy?
Esmaeilzadeh, A., Pouyan, S., & Erfanmanesh, M. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.02.048 · Cited by 14
Ganbaatar, B., Fukuda, D., Shinohara, M., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., Hirata, K., & Sata, M. (2020) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.54916 · Cited by 14
Li, R.-J., Zhou, Y.-L., Liu, W., Li, Y., Qin, Y., Yu, L.-L., Chen, Y., & Xu, Y.-J. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111195 · Cited by 14
Kamarullah, W., Nurcahyani, Multazam, R. B., & Josephine, C. M. (2021) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2021.1948715 · Cited by 14
Ryu, J., Jung, I., Park, E. Y., Kim, K., Kim, K., Yeom, J., Jung, J., & Lee, S. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17233 · Cited by 12
Stavri, S., Simionescu, M., Kardassis, D., & Gafencu, A. V. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.163 · Cited by 14
Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities
Schiattarella, G. G., Madonna, R., Linthout, S. V., Thum, T., Schulz, R., Ferdinándy, P., & Perrino, C. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.02.009 · Cited by 14
Survivin regulated by autophagy mediates hyperglycemia-induced vascular endothelial cell dysfunction
Xu, Y., Huang, C., Liu, M., Chen, N., Chen, W., Chen, Y., Zhao, Y., Li, X., Duan, J., Liu, S., et al. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.01.037 · Cited by 14
The Development and Regeneration of Coronary Arteries
He, L., & Zhou, B. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0999-2 · Cited by 13
Zhou, Y., Liu, X., Huang, N., & Chen, Y. (2018) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34192 · Cited by 14
Ludvigsen, T. P., Pedersen, S., Vegge, A., Ripa, R. S., Johannesen, H. H., Hansen, A. E., Löfgren, J., Schumacher-Petersen, C., Kirk, R. K., Pedersen, H. D., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.04.209 · Cited by 14
Gremlin-1 potentiates the dedifferentiation of VSMC in early stages of atherosclerosis
de Barros, R. S., Dias, G. S., do Rosario, A. P., Paladino, F. V., Lopes, G. H., & Campos, A. H. (2019) · Differentiation · doi:10.1016/j.diff.2019.08.001 · Cited by 14
Vascular Diseases and Gangliosides
Sasaki, N., & Toyoda, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246362 · Cited by 15
Alfaidi, M., Bhattarai, U., & Orr, A. W. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016099 · Cited by 14
Patel, S., & Werstuck, G. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676752 · Cited by 15
Neutrophils in Acute Coronary Syndrome
Kurup, R., & Patel, S. (2017) · EMJ Cardiology · doi:10.33590/emjcardiol/10314937 · Cited by 15
Neurocardiology and Atherosclerosis: The Effect of Ethnic Differences on Heart-brain Interaction
Markousis‐Mavrogenis, G. (2017) · Journal of Neurosciences in Rural Practice · doi:10.4103/jnrp.jnrp_143_17 · Cited by 14
Liang, M., Guo, Q., Huang, F., Han, G., Song, K., Luo, J., Cheng, H., Hu, H., Peden, E. K., Chen, C., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.027 · Cited by 13
Singh, A., & Sen, P. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158981 · Cited by 13
Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy
Li, Y., Feng, Q., Wang, L., Gao, X., Xi, Y., Ye, L., Ji, J., Yang, X., & Zhai, G. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2023.2300694 · Cited by 13
Sun, H., Ma, X., Ma, H., Li, S., Xia, Y., Yao, L., Wang, Y., Pang, X., Zhong, J., Yao, G., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149702 · Cited by 13
Role of inflammasomes in endothelial dysfunction
Wu, J., Shyy, M., Shyy, J. Y. ‐., & Xiao, H. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16479 · Cited by 14
He, T., Pu, J., Ge, H., Liu, T., Lv, X., Zhang, Y., Cao, J., Yu, H., Lu, Z., & Du, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-76243-x · Cited by 13
Rampersad, S. N., Freitag, S. I., Hubert, F., Brzezinska, P. B., Butler, N., Umana, M. B., Wudwud, A., & Maurice, D. H. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.016 · Cited by 13
Kim, H., Kim, S., Baek, S. H., & Kwon, S. (2016) · Stem Cells International · doi:10.1155/2016/8340257 · Cited by 13
Nutrition and atherosclerotic cardiovascular disease
Sapp, P. A., Riley, T. M., Tindall, A. M., Sullivan, V. K., Johnston, E. A., Petersen, K. S., & Kris‐Etherton, P. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818460-8.00022-8 · Cited by 14
Peters, E. B., Karver, M. R., Sun, K., Gillis, D. C., Biswas, S., Clemons, T. D., He, W., Tsihlis, N. D., Stupp, S. I., & Kibbe, M. R. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100103 · Cited by 13
Non-viral nucleic acid therapeutics: Revolutionizing the landscape of atherosclerotic treatment
Qu, S., Liu, R., Zhang, N., Xu, Y., Yue, X., & Dai, Z. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101514 · Cited by 14
Spite, M. R., & Fredman, G. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2022.12.005 · Cited by 13
Role of HDL-Associated Proteins and Lipids in the Regulation of Inflammation
White, R., Giordano, S. S., & Datta, G. (2017) · InTech eBooks · doi:10.5772/67141 · Cited by 15
Fu, W., Liu, Z., Zhang, J., Shi, Y., Zhao, R., & Zhao, H. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8369 · Cited by 13
Jiang, W., Zhao, W., Ye, F., Huang, S., Wu, Y., Chen, H., Zhou, R., & Fu, G. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.11.006 · Cited by 13
Xing, Z., Zhen, Y., Chen, J., Du, M., Li, D., Liu, R., & Zheng, J. (2023) · Inflammation · doi:10.1007/s10753-023-01863-w · Cited by 12
McGarrity, S., Halldórsson, H., Palsson, S., Johansson, P. I., & Rolfsson, Ó. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2016.00010 · Cited by 12
Liang, J., Li, W., Liu, H., Li, X., Yuan, C., Zou, W., & Qu, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.857092 · Cited by 12
Yin, Y., Xie, Z., Chen, D., Guo, H., Han, M., Zhu, Z., & Bi, J. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01259-z · Cited by 12
Thakur, M., & Tupe, R. S. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106698 · Cited by 13
A novel role for YPEL2 in mediating endothelial cellular senescence via the p53/p21 pathway
Xu, J., Tang, M.-L., Lu, Z.-F., Song, Y., Zhang, K., He, R.-C., Guo, X., Yuan, Y.-Q., Dai, X., & Ma, X. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111803 · Cited by 12
Oladosu, O., Esobi, I. C., Powell, R. R., Bruce, T. F., & Stamatikos, A. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10100416 · Cited by 12
Terriaca, S., Ferlosio, A., Scioli, M. G., Coppa, F., Bertoldo, F., Pisano, C., Belmonte, B., Balistreri, C. R., & Orlandi, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052641 · Cited by 12
Barbarroja, N., López‐Medina, C., Escudero‐Contreras, A., & de la Rosa, I. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1459185 · Cited by 12
Yamamoto, K., Tajima, Y., Hasegawa, A., Takahashi, Y., Kojima, M., Watanabe, R., Sato, K., Shichiri, M., & Watanabe, T. (2016) · Peptides · doi:10.1016/j.peptides.2016.06.009 · Cited by 12
Inflammatory Mechanisms in Atherosclerosis
Gregersen, I., & Halvorsen, B. L. (2018) · InTech eBooks · doi:10.5772/intechopen.72222 · Cited by 13
Long Noncoding RNA TUG1 Promotes the Function in ox-LDL-Treated HA-VSMCs via miR-141-3p/ROR2 Axis
Tang, Y., Hu, J., Zhong, Z., Liu, Y., & Wang, Y. (2020) · Cardiovascular Therapeutics · doi:10.1155/2020/6758934 · Cited by 12
Liu, M., Yu, T., Li, M., Fang, X., Hou, B., Liu, G., & Wang, J. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.08.003 · Cited by 12
Recent efforts in drug discovery on vascular inflammation and consequent atherosclerosis
Martelli, A., Citi, V., & Calderone, V. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1850688 · Cited by 12
Wang, L., Wang, J., Xu, J., Qin, W., Wang, Y., Luo, S., & Wang, G. (2021) · Applied Sciences · doi:10.3390/app11199078 · Cited by 12
Zheng, X., Liu, J., Gong, X., Zhang, X., & Ma, S. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001143 · Cited by 12
Rotllan, N., Zhang, X.-B., Canfrán-Duque, A., Goedeke, L., Griñán, R., Ramírez, C., Suárez, Y., & Fernández-Hernando, C. (2022) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2022.113419 · Cited by 11
Wu, Y., Zhang, J.-J., Li, T., Liu, W., Li, L., Luo, X., Jiang, J., Ma, Q., Yang, Z., & Peng, J. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416634465 · Cited by 12
Chronic stress: a crucial promoter of cell apoptosis in atherosclerosis
Meng, L., Shan, M., Yu, Z.-M., Lv, J., Qi, R., Guo, P., Zhang, Y.-M., & Gong, T. (2019) · Journal of International Medical Research · doi:10.1177/0300060518814606 · Cited by 12
Li, D., & Tan, Y. C. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7316 · Cited by 12
RetractedAnti-β2GPI antibodies enhance atherosclerosis in ApoE-deficient mice
Wang, X., Zhu, X., Zhou, H., Xia, L., Wang, T., Wang, Z., Li, Y., Yan, J., & Wang, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.020 · Cited by 10
MiR-210 inhibits hypoxia-induced apoptosis of smooth muscle cells via targeting MEF2C.
Bao, Q., Jia, H., Rong, A., Cao, Z., & Zhang, Y. (2019) · Europe PMC (PubMed Central) · Cited by 12
Visualization of endothelial barrier damage prior to formation of atherosclerotic plaques
Bömmel, H. M., Kleefeldt, F., Zernecke, A., Ghavampour, S., Wagner, N., Küerten, S., & Ergün, S. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1562-8 · Cited by 13
VLDL Induced Modulation of Nitric Oxide Signalling and Cell Redox Homeostasis in HUVEC
Magnifico, M. C., Oberkersch, R. E., Mollo, A., Giambelli, L., Grooten, Y., Sarti, P., Calabrese, G. C., & Arese, M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2697364 · Cited by 12
Risk Factors of Atherosclerosis
Tsioufis, C. P., Mantzouranis, E., Kalos, T., Konstantinidis, D., & Tousoulis, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811908-2.00004-0 · Cited by 13
Houben, T., dos Reis, I. M., Oligschlaeger, Y., Steinbusch, H. P., Gijbels, M. J., Hendrikx, T., Binder, C. J., Cassiman, D. M., Westerterp, M., Prickaerts, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03089 · Cited by 12
Cellular and Molecular Mechanisms of VSMC Phenotypic Switching in Type 2 Diabetes
Gupta, S., Hernandez, G., & Raman, P. (2025) · Cells · doi:10.3390/cells14171365 · Cited by 12
Chen, R., Chen, T., Zhou, Z., Song, Z., Feng, W., Yang, X., Wang, X., Li, B., Ding, X., Zhang, H., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.937737 · Cited by 11
Bi, Y., Liang, H., Han, X., Li, K., Zhang, W., Lai, Y., Wang, Q., Jiang, X., Zhao, X., & Fan, H. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/9241090 · Cited by 11
Roles and mechanisms of histone methylation in vascular aging and related diseases
Ji, Y., Chen, Z., & Cai, J. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01842-y · Cited by 12
Zhang, H.-M., de Urturi, D. S., Fernández-Tussy, P., Huang, Y., Jovin, D. G., Zhang, X.-B., Huang, S.-S., Lek, M., Catarino, J. D. S., Sternak, M., et al. (2025) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2417512122 · Cited by 12
Gene transfer to the vascular system: Novel translational perspectives for vascular diseases
Remes, A. K., Basha, D. I., Frey, N., Wagner, A. H., & Müller, O. J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114265 · Cited by 11
Millet shell polyphenols ameliorate atherosclerosis development by suppressing foam cell formation
Liu, F., Shan, S., Li, H., Shi, J., Yang, R., & Li, Z. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109271 · Cited by 12
The TICE Pathway: Mechanisms and Potential Clinical Applications
Xu, H., Xin, Y., Wang, J., Liu, Z., Cao, Y., Li, W., Zhou, Y., Wang, Y., & Liu, P. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01147-6 · Cited by 11
Lithium and zinc levels along with oxidative status in myocardial infarction: A case-control study
Shiri, H., Sagha, A., Nasri, H., Mehdeipour, S., Fooladi, S., Mehrabani, M., Farhadi, S., Kharazmi, S., & Nematollahi, M. H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21875 · Cited by 11
Lü, W., Wan, G., Zhu, H., Zhu, T., & Zhang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28887 · Cited by 11
Prucnal, M., Gercken, B., Economopoulou, M., Hajishengallis, G., Chavakis, T., & Subramanian, P. (2017) · Thrombosis and Haemostasis · doi:10.1160/th17-03-0160 · Cited by 11
Kim, Y., Noh, J., Hwang, J. S., Kim, K., Choi, D., An, J., Oh, W. K., & Lee, C. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5271 · Cited by 11
Metadata
- Authors
- Tabas, I., García-Cardeña, G., & Owens, G. K.
- Affiliations
- Columbia University Irving Medical Center (US)
- Program in Human Biology and Translational Medicine, Harvard Medical School, Boston, MA 02115 4
- University of Virginia (US)
- Corresponding author
- Tabas, Ira
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2015-04-13
- Volume
- 209
- Issue
- 1
- Pages
- 13-22
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC4395483
- OpenAlex
- W1949072443
- Cited by
- 1,016
- References
- 107
- Citations by year
- 2026: 45 · 2025: 68 · 2024: 70 · 2023: 96 · 2022: 107 · 2021: 94 · 2020: 96 · 2019: 124 · 2018: 108 · 2017: 103 · 2016: 78 · 2015: 23
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (AG032443, R01AG032443)
- National Heart, Lung, and Blood Institute (R44HL118826, HL057353, HL087867, HL107497, HL075662, HL121008, HL118826, R01HL087867, R01HL057353, R01HL075662, R37HL057353, R01HL121008, R01HL107497, R41HL118826)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- atherosclerosis, endothelial dysfunction, disturbed blood flow, nonresolving inflammation, arterial thrombosis, end-organ ischemia, mechanotransduction, endothelial inflammation, macrophage origin, smooth muscle cell phenotypic switching, atherosclerosis treatment
- MeSH terms
- Animals, Endothelium, Vascular, Humans, Macrophages, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Mechanotransduction, Cellular, Endothelial Cells, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
